PFIZER INC Amortization of Intangible Assets
PFIZER INC (PFE) reported Amortization of Intangible Assets of $3.60 billion for the 9-month period ending 2025-09-28, per its 10-Q filed 2025-11-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-11-04
- PFIZER INC amortization of intangible assets for the quarter ending 2025-09-28 was $1.20B, a 7.69% decline year-over-year.
- PFIZER INC amortization of intangible assets for the quarter ending 2025-06-29 was $1.20B, a 7.69% decline year-over-year.
- PFIZER INC amortization of intangible assets for the quarter ending 2025-03-30 was $1.20B, a 7.69% decline year-over-year.
- PFIZER INC amortization of intangible assets for the quarter ending 2024-12-31 was $1.40B, a 16.67% increase year-over-year.
- PFIZER INC amortization of intangible assets for fiscal 2024 was $5.30B, a 12.77% increase from fiscal 2023.
- PFIZER INC amortization of intangible assets for fiscal 2023 was $4.70B, a 30.56% increase from fiscal 2022.
- PFIZER INC amortization of intangible assets for fiscal 2022 was $3.60B, a 2.70% decline from fiscal 2021.
- PFIZER INC amortization of intangible assets for fiscal 2021 was $3.70B, a 8.82% increase from fiscal 2020.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-28 | $1.20B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.40B derived: sum of 2 quarters · filed 2025-11-04 | $3.60B 10-Q · filed 2025-11-04 | $5.00B derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2025-06-29 | $1.20B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $2.40B 10-Q · filed 2025-08-05 | $3.80B derived: sum of 3 quarters · filed 2025-08-05 | $5.10B derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2025-03-30 | $1.20B 10-Q · filed 2025-05-05 | $2.60B derived: sum of 2 quarters · filed 2025-05-05 | $3.90B derived: sum of 3 quarters · filed 2025-05-05 | $5.20B derived: sum of 4 quarters · filed 2025-05-05 | ||||
| 2024-12-31 | $1.40B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.70B derived: sum of 2 quarters · filed 2025-02-27 | $4.00B derived: sum of 3 quarters · filed 2025-02-27 | $5.30B 10-K · filed 2025-02-27 | ||||
| 2024-09-29 | $1.30B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $2.60B derived: sum of 2 quarters · filed 2024-11-04 | $3.90B 10-Q · filed 2024-11-04 | $5.10B derived: sum of 4 quarters · filed 2024-11-04 | ||||
| 2024-06-30 | $1.30B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $2.60B 10-Q · filed 2024-08-05 | $3.80B derived: sum of 3 quarters · filed 2024-08-05 | $5.00B derived: sum of 4 quarters · filed 2024-08-05 | ||||
| 2024-03-31 | $1.30B 10-Q · filed 2024-05-08 | $2.50B derived: sum of 2 quarters · filed 2024-05-08 | $3.70B derived: sum of 3 quarters · filed 2024-05-08 | |||||
| 2023-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.40B derived: sum of 2 quarters · filed 2024-02-22 | $4.70B 10-K · filed 2024-02-22 | |||||
| 2023-10-01 | $1.20B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.50B 10-Q · filed 2023-11-08 | ||||||
| 2023-07-02 | $2.30B 10-Q · filed 2023-08-09 | |||||||
| 2022-12-31 | $3.60B 10-K · filed 2023-02-23 | |||||||
| 2021-12-31 | $3.70B 10-K · filed 2023-02-23 | |||||||
| 2020-12-31 | $3.40B 10-K · filed 2023-02-23 | |||||||
| 2019-12-31 | $4.50B 10-K · filed 2022-02-24 | |||||||
| 2015-12-31 | $3.80B 10-K · filed 2016-02-29 | |||||||
| 2014-12-31 | $4.10B 10-K · filed 2016-02-29 | |||||||
| 2013-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.30B derived: sum of 2 quarters · filed 2016-02-29 | $3.50B derived: sum of 3 quarters · filed 2016-02-29 | $4.80B 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | $1.10B 10-Q · filed 2013-11-08 | $2.30B derived: sum of 2 quarters · filed 2013-11-08 | $3.60B 10-Q · filed 2013-11-08 | $4.90B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $1.20B 10-Q · filed 2013-08-09 | $2.50B 10-Q · filed 2013-08-09 | $3.80B derived: sum of 3 quarters · filed 2015-02-27 | $5.00B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $1.30B 10-Q · filed 2013-05-10 | $2.60B derived: sum of 2 quarters · filed 2015-02-27 | $3.80B derived: sum of 3 quarters · filed 2015-02-27 | $5.10B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $1.30B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $2.50B derived: sum of 2 quarters · filed 2015-02-27 | $3.80B derived: sum of 3 quarters · filed 2015-02-27 | $5.30B 10-K · filed 2015-02-27 | $5.40B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $1.20B 10-Q · filed 2013-11-08 | $1.30B 10-Q · filed 2012-11-09 | $2.50B derived: sum of 2 quarters · filed 2013-11-08 | $4.00B 10-Q · filed 2013-11-08 | $4.10B 10-Q · filed 2012-11-09 | $5.40B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $1.30B 10-Q · filed 2013-08-09 | $2.80B 10-Q · filed 2013-08-09 | $4.20B derived: sum of 3 quarters · filed 2014-02-28 | $5.60B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-04-01 | $1.50B 10-Q · filed 2013-05-10 | $1.42B 10-Q · filed 2012-05-10 | $2.90B derived: sum of 2 quarters · filed 2014-02-28 | $4.30B derived: sum of 3 quarters · filed 2014-02-28 | $5.70B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $1.40B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $2.80B derived: sum of 2 quarters · filed 2014-02-28 | $4.20B derived: sum of 3 quarters · filed 2014-02-28 | $5.70B 10-K · filed 2014-02-28 | $5.58B 10-K · filed 2012-02-28 | |||
| 2011-10-02 | $1.40B 10-Q · filed 2012-11-09 | $1.40B 10-Q · filed 2011-11-10 | $2.80B derived: sum of 2 quarters · filed 2012-11-09 | $4.30B 10-Q · filed 2012-11-09 | $4.17B 10-Q · filed 2011-11-10 | $5.70B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-07-03 | $1.40B 10-Q · filed 2011-08-11 | $2.90B 10-Q · filed 2012-08-09 | $2.77B 10-Q · filed 2011-08-11 | $4.30B derived: sum of 3 quarters · filed 2013-02-28 | $5.46B derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-04-03 | $1.38B 10-Q · filed 2012-05-10 | $2.90B derived: sum of 2 quarters · filed 2013-02-28 | $4.06B derived: sum of 3 quarters · filed 2013-02-28 | $5.47B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $2.68B derived: sum of 2 quarters · filed 2013-02-28 | $4.09B derived: sum of 3 quarters · filed 2013-02-28 | $5.50B 10-K · filed 2013-02-28 | $5.40B 10-K · filed 2011-02-28 | |||
| 2010-10-03 | $1.16B 10-Q · filed 2011-11-10 | $2.56B derived: sum of 2 quarters · filed 2011-11-10 | $3.97B 10-Q · filed 2011-11-10 | $5.09B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-07-04 | $1.41B 10-Q · filed 2011-08-11 | $2.82B 10-Q · filed 2011-08-11 | $3.94B derived: sum of 3 quarters · filed 2012-02-28 | $4.53B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-04-04 | $1.41B 10-Q · filed 2011-05-12 | $2.53B derived: sum of 2 quarters · filed 2012-02-28 | $3.13B derived: sum of 3 quarters · filed 2012-02-28 | $3.71B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2009-12-31 | $1.12B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $1.72B derived: sum of 2 quarters · filed 2012-02-28 | $2.30B derived: sum of 3 quarters · filed 2012-02-28 | $2.88B 10-K · filed 2012-02-28 | ||||
| 2009-09-27 | $594.00M 10-Q · filed 2010-11-12 | $1.18B derived: sum of 2 quarters · filed 2010-11-12 | $1.75B 10-Q · filed 2010-11-12 | $2.36B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-28 | $583.00M 10-Q · filed 2010-08-12 | $1.16B 10-Q · filed 2010-08-12 | $1.77B derived: sum of 3 quarters · filed 2011-02-28 | $2.39B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-29 | $578.00M 10-Q · filed 2010-05-13 | $1.18B derived: sum of 2 quarters · filed 2011-02-28 | $1.80B derived: sum of 3 quarters · filed 2011-02-28 | $2.47B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $605.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $1.23B derived: sum of 2 quarters · filed 2011-02-28 | $1.89B derived: sum of 3 quarters · filed 2011-02-28 | $2.67B 10-K · filed 2011-02-28 | ||||
| 2008-09-28 | $621.00M 10-Q · filed 2009-11-05 | $1.28B derived: sum of 2 quarters · filed 2009-11-05 | $2.06B 10-Q · filed 2009-11-05 | |||||
| 2008-06-29 | $663.00M 10-Q · filed 2009-08-06 | $1.44B 10-Q · filed 2009-08-06 | ||||||
| 2007-12-31 | $3.13B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |